 Connection
Vincent Chen to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Vincent Chen has written about Carcinoma, Hepatocellular.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.673 |
|
|
|
-
Chen VC, Chan HL, Hsu TC, Lu ML, Lee YC, Lee Y, Siow JY, McIntyre RS, Zhou AJ, Tzang BS, Lee CT. New use for old drugs: The protective effect of atypical antipsychotics on hepatocellular carcinoma. Int J Cancer. 2019 05 15; 144(10):2428-2439.
Score: 0.468
-
Chan HL, Chiu WC, Chen VC, Huang KY, Wang TN, Lee Y, McIntyre RS, Hsu TC, Lee CT, Tzang BS. SSRIs associated with decreased risk of hepatocellular carcinoma: A population-based case-control study. Psychooncology. 2018 01; 27(1):187-192.
Score: 0.106
-
Wang C, Chen V, Vu V, Le A, Nguyen L, Zhao C, Wong CR, Nguyen N, Li J, Zhang J, Trinh H, Nguyen MH. Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Medicine (Baltimore). 2016 Aug; 95(35):e4744.
Score: 0.099
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|